Cell Biology

Pyroptosis

Inflammatory cell death — inflammasome, caspase-1, gasdermin D pores, IL-1β release

Pyroptosis is inflammatory, lytic programmed cell death — an infected or danger-sensing cell deliberately bursts to alert the immune system, the exact opposite of quiet, tidy apoptosis. A cytosolic sensor assembles an inflammasome that activates caspase-1, which cleaves gasdermin D; the freed N-terminal fragments oligomerize into rings of roughly 27–33 subunits and punch 10–20 nm pores in the plasma membrane, releasing the mature alarm cytokines IL-1β and IL-18 before the cell swells and ruptures. The term was coined in 2001 by Brad Cookson and Molly Brennan (Greek pyro, fire + ptosis, falling); gasdermin D was unmasked as the executioner pore in 2015 by the Shao and Dixit/Lieberman groups. It is a frontline defense against intracellular pathogens such as Salmonella, Shigella, and Legionella.

  • Death typeLytic, pro-inflammatory
  • ExecutionerGasdermin D pore
  • Pore size~10–20 nm inner diameter
  • ProteaseCaspase-1 / -4 / -5 (-11)
  • Cytokines releasedIL-1β, IL-18
  • CoinedCookson & Brennan, 2001

Interactive visualization

Press play, or step through manually. The visualization is yours to drive — try it before reading on.

Open visualization fullscreen ↗

Watch the 60-second explainer

A condensed visual walkthrough — narrated, captioned, under a minute.

Why pyroptosis matters

  • It clears the intracellular pathogen niche. Bacteria like Salmonella Typhimurium, Shigella flexneri, Legionella pneumophila, Listeria, and Francisella hide inside cells where antibodies and complement cannot reach. A macrophage that senses the intruder in its cytosol and then ruptures destroys the replicative niche and ejects the bacteria into the open, where neutrophils and complement can finish them.
  • Pore-induced intracellular traps (PITs). When a pyroptotic macrophage bursts, it does not scatter live bacteria freely — the bacteria stay trapped in the membrane remnant, a structure named a PIT. Incoming neutrophils recognize and clear these traps by efferocytosis, so pyroptosis and neutrophil killing operate as a relay, not a scatter-shot.
  • It matures and releases IL-1β and IL-18. These cytokines have no signal peptide and cannot leave through the conventional secretory route. They are synthesized as inactive precursors, cleaved by caspase-1, and released through the gasdermin D pore — a form of unconventional secretion that couples cytokine export directly to the death program.
  • It is a druggable inflammatory hub. Gain-of-function NLRP3 mutations cause the cryopyrin-associated periodic syndromes (CAPS); the IL-1 blockers anakinra, canakinumab, and rilonacept treat them. The CANTOS trial (2017) showed the anti-IL-1β antibody canakinumab cut recurrent cardiovascular events, direct clinical proof that inflammasome output drives atherosclerosis.
  • It sculpts sterile inflammatory disease. Cholesterol crystals in plaques, monosodium urate crystals in gout, silica and asbestos in the lung, and islet amyloid in type 2 diabetes all activate NLRP3, linking pyroptosis to some of the most common chronic diseases rather than only to infection.
  • It drives CD4 T-cell loss in HIV. Abortive HIV infection of resting lymphoid CD4 T cells triggers caspase-1-dependent pyroptosis; this — not direct viral killing of productively infected cells — accounts for the bulk of the CD4 depletion that defines AIDS, which is why caspase-1 inhibition was proposed as an anti-inflammatory adjunct.
  • Gasdermins are an ancient pore-forming family. Gasdermin D is one of at least six human gasdermins (GSDMA–E, plus PJVK/DFNB59). Gasdermin E is cleaved by apoptotic caspase-3 to convert stalled apoptosis into secondary pyroptosis, and gasdermin-like pore formers exist in bacteria and fungi, marking this as a deeply conserved defense mechanism.

Common misconceptions

  • "Pyroptosis is just necrosis." Early observers grouped the swelling, lytic morphology with accidental necrosis. It is not: pyroptosis is genetically programmed, requires specific inflammatory caspases and gasdermin D, and produces a defined pore of controlled size. Genetic deletion of caspase-1 or gasdermin D abolishes it, which no accidental death would allow.
  • "Caspase-1 kills by cleaving the same substrates as caspase-3." Inflammatory and apoptotic caspases have almost no overlap in substrates. Caspase-1's decisive death substrate is gasdermin D — not the ICAD/CAD, lamin, or PARP substrates of executioner caspases-3/7. A cell with active caspase-1 but no gasdermin D releases little and survives longer, dying by a slower apoptosis-like route.
  • "The gasdermin D pore is what kills the cell directly." The pore itself does not shred the cell; it collapses the ion gradients. Potassium leaves, sodium and calcium enter, water follows osmotically, and the cell swells until the membrane fails. The ninjurin-1 (NINJ1) protein was shown in 2021 to drive the final plasma-membrane rupture, so lysis is itself a regulated step downstream of the pore.
  • "IL-1β is secreted like a normal protein." Pro-IL-1β lacks a signal peptide and never enters the ER–Golgi secretory pathway. It is matured in the cytosol by caspase-1 and exits through the gasdermin D pore. Block the pore and the cytokine stays trapped inside — pore formation and cytokine release are mechanically the same event.
  • "Non-canonical pyroptosis makes its own IL-1β." Caspase-4/5/11 bind cytosolic LPS and cleave gasdermin D for lysis, but they cannot process pro-IL-1β directly. The potassium efflux through the resulting pore activates NLRP3 secondarily, recruiting caspase-1 to mature the cytokine. The lytic and cytokine arms are split between two caspases.
  • "Only immune cells undergo pyroptosis." Macrophages, monocytes, and dendritic cells are the classic responders, but intestinal and airway epithelium, keratinocytes, and endothelium also express gasdermin D and inflammasome sensors and can pyroptose — epithelial pyroptosis expels infected enterocytes into the gut lumen as a barrier-defense mechanism.

How pyroptosis works, step by step

Pyroptosis begins with a cytosolic sensor detecting a pathogen- or danger-associated signal that has no business being in the cytoplasm. Different sensors recognize different threats: NLRP3 is a general danger sensor triggered downstream of potassium efflux, lysosomal rupture, mitochondrial damage, extracellular ATP (via the P2X7 channel), and particulate crystals; NLRC4, aided by NAIP proteins, recognizes bacterial flagellin and the rod and needle proteins of type III secretion systems; AIM2 binds cytosolic double-stranded DNA; and Pyrin senses toxins that inactivate host RhoA. On activation, the sensor nucleates the adaptor ASC, whose PYD and CARD domains self-polymerize into filaments that condense into a single micron-scale "ASC speck" — a one-per-cell hallmark of inflammasome assembly.

The ASC speck clusters many molecules of pro-caspase-1 through CARD–CARD interactions. Forced into proximity, pro-caspase-1 undergoes proximity-induced dimerization and autoprocessing to become active caspase-1. This is the canonical route. In the non-canonical route, the inflammatory caspases-4 and -5 in humans (caspase-11 in mice) skip the sensor entirely: their CARD domains are themselves direct receptors for cytosolic lipopolysaccharide (LPS) from Gram-negative bacteria, so contact with LPS oligomerizes and activates them.

Active caspase-1 (or -4/-5/-11) then cleaves gasdermin D at Asp275 in the linker between its lipid-binding N-terminal domain and its autoinhibitory C-terminal domain. Freed from autoinhibition, the N-terminal fragments diffuse to the membrane, bind acidic inner-leaflet lipids (phosphatidylserine, phosphoinositides) and, on bacterial membranes, cardiolipin. There, roughly 27 to 33 protomers oligomerize into a ring and insert a beta-barrel transmembrane pore of about 10–20 nm inner diameter — one of the largest channels in cell biology, wide enough to pass a folded 17 kDa cytokine.

Two things now happen at once. First, the mature cytokines IL-1β and IL-18 — cleaved from their precursors by the same caspase-1 — escape through the pore, alarming and recruiting neutrophils, driving fever, and priming neighbors. Second, the pore dissipates the ionic gradients: potassium floods out, sodium and calcium rush in, water follows osmotically, and the cell balloons. The final plasma-membrane rupture is executed by the membrane protein NINJ1, spilling danger-associated molecular patterns (DAMPs) such as HMGB1, ATP, and IL-1α. The whole program — from speck to lysis — plays out in tens of minutes, converting one compromised cell into a loud, coordinated immune alarm.

Pyroptosis vs apoptosis vs necroptosis vs necrosis

FeaturePyroptosisApoptosisNecroptosisNecrosis (accidental)
TriggerInflammasomes (NLRP3, NLRC4, AIM2), cytosolic LPSBH3-only proteins / death receptorsDeath receptors + caspase-8 blockEnergy failure, severe injury
Key effectorsCaspase-1/-4/-5/-11, gasdermin DCaspases-3/7/8/9RIPK1, RIPK3, MLKLNone (passive)
Membrane fateGasdermin D pores → swelling → lysisIntact, blebs outwardMLKL pores → lysisRuptures, swells
InflammationVery high (IL-1β, IL-18, DAMPs)Silent (anti-inflammatory)High (DAMPs)High (DAMPs)
DNANicked, no laddering180-bp ladderingRandom degradationRandom degradation
Programmed?YesYesYesNo
Main roleAnti-intracellular-pathogen defenseHomeostasis, tissue sculptingBackup death when apoptosis is blockedInjury response
Drug targetNLRP3 (MCC950), GSDMD (disulfiram), IL-1 (canakinumab)BCL-2 (venetoclax)RIPK1 (necrostatins)

Canonical vs non-canonical pyroptosis

PropertyCanonicalNon-canonical
Upstream triggerPAMP/DAMP sensed by NLRP3, NLRC4, AIM2, or PyrinCytosolic LPS binding the caspase CARD directly
Adaptor / platformASC speck (for most sensors)None — caspase is its own sensor
Active caspaseCaspase-1Caspase-4 / -5 (human); caspase-11 (mouse)
Cleaves gasdermin DYesYes
Cleaves pro-IL-1β / IL-18 directlyYesNo (cannot process the cytokines)
Cytokine maturationSame caspase-1 eventIndirect: K⁺ efflux → NLRP3 → caspase-1
Pathogen class targetedBroad (flagellated, DNA, toxin, crystals)Gram-negative bacteria (LPS-bearing)

Famous experiments and history

  • Zychlinsky and Shigella (1992–1996). Arturo Zychlinsky's group found that Shigella-infected macrophages died in a way that required the protease then called ICE (interleukin-1-converting enzyme, now caspase-1) and released IL-1β — the first hint that a caspase could drive inflammatory, not apoptotic, death.
  • Cookson and Brennan coin "pyroptosis" (2001). Studying Salmonella-infected macrophages, Brad Cookson and Molly Brennan named the caspase-1-dependent, pro-inflammatory death "pyroptosis" — Greek for "falling by fire" — to distinguish it firmly from apoptosis in Trends in Microbiology and Cellular Microbiology.
  • Gasdermin D unmasked (2015). Two teams — one led by Feng Shao, one by Vishva Dixit and Judy Lieberman — used forward-genetic and CRISPR screens to show that gasdermin D is the essential caspase-1/-11 substrate; cleaving it releases an N-terminal fragment that is necessary and sufficient for pyroptotic lysis. This solved a mechanism that had been open since 2001.
  • The pore is visualized (2016). Cryo-EM and atomic-force microscopy from the Shao, Wu, and Ruan groups resolved the gasdermin D N-terminal fragment as a large membrane-spanning ring of ~27–33 subunits with a ~10–20 nm lumen, explaining how a folded cytokine can pass through and how ions collapse.
  • Non-canonical LPS sensing (2013–2014). Work from the Dixit and Shao labs showed that caspase-11 (and human caspase-4/5) bind intracellular LPS directly through their CARD domains — the caspases are themselves the pattern-recognition receptors, a striking exception to the sensor-adaptor-caspase paradigm.
  • NINJ1 executes rupture (2021). A genome-wide screen from the Kayagaki/Dixit group identified ninjurin-1 (NINJ1) as the protein that drives the final plasma-membrane rupture in pyroptosis and other lytic deaths, showing that even cell bursting is genetically programmed rather than passive.

Frequently asked questions

How is pyroptosis different from apoptosis?

Apoptosis is silent and non-lytic: the cell shrinks, blebs its membrane outward into intact apoptotic bodies, keeps its contents sealed, and is engulfed by phagocytes with no inflammation. Pyroptosis is the opposite — it is lytic and deliberately inflammatory. A gasdermin D pore is punched into the plasma membrane, the cell swells and ruptures, and it spills its contents, including the mature alarm cytokines IL-1beta and IL-18 and danger-associated molecular patterns (DAMPs) like HMGB1 and ATP. Apoptosis runs on caspases-3, -7, -8, and -9; pyroptosis runs on the inflammatory caspases-1, -4, -5 (and caspase-11 in mice). The morphologies also differ: apoptotic cells show chromatin condensation and DNA laddering, whereas pyroptotic cells swell (a phenotype once mistaken for necrosis) with only nicked, non-laddered DNA and a characteristic ballooned membrane before it bursts.

What is the inflammasome and how does it trigger pyroptosis?

An inflammasome is a cytosolic supramolecular complex that senses infection or danger and activates inflammatory caspase-1. It is built from three parts: a sensor, the adaptor ASC, and pro-caspase-1. Sensors include NLRP3 (responding to potassium efflux, lysosomal rupture, ATP, crystals like monosodium urate and cholesterol), NLRC4 (bacterial flagellin and type III secretion rods via NAIP proteins), AIM2 (cytosolic double-stranded DNA), and Pyrin (bacterial toxins that inactivate host RhoA). Once triggered, the sensor nucleates ASC into a single micron-scale 'ASC speck' whose PYD and CARD domains polymerize into filaments. These filaments cluster many pro-caspase-1 molecules, forcing their proximity-induced dimerization and autoprocessing. Active caspase-1 then cleaves gasdermin D and the pro-cytokines pro-IL-1beta and pro-IL-18, executing pyroptosis and releasing the mature cytokines.

How does gasdermin D form pores in the membrane?

Gasdermin D (GSDMD) is normally kept inactive because its lipid-binding N-terminal pore domain is folded against an autoinhibitory C-terminal domain. Caspase-1 (canonical) or caspase-4/5/11 (non-canonical) cleaves the linker after Asp275 in human GSDMD, freeing the N-terminal fragment. The released fragments bind acidic membrane lipids — phosphatidylserine and phosphatidylinositol phosphates on the inner leaflet, and cardiolipin on bacterial membranes — then oligomerize. Typically 27 to 33 protomers assemble into a ring and insert a beta-barrel transmembrane pore roughly 10 to 20 nm in inner diameter, one of the largest known biological channels. That is wide enough to pass mature IL-1beta (about 17 kDa) and IL-18 while collapsing the sodium and potassium gradients; water follows the ions, the cell swells, and it lyses. Because it targets acidic inner-leaflet and bacterial lipids, GSDMD can also perforate the membranes of engulfed bacteria directly.

Why does the body use a cell-death pathway that causes inflammation?

Pyroptosis is a host-defense strategy aimed at intracellular pathogens. Bacteria such as Salmonella, Shigella, Legionella, Listeria, and Francisella hide inside cells where antibodies and complement cannot reach them. By detecting the intruder in the cytosol and then rupturing, an infected macrophage destroys the replicative niche and physically ejects the bacteria into the extracellular space, where neutrophils and complement can finish them. The released IL-1beta and IL-18 recruit and activate those neutrophils, drive fever, and prime nearby cells. Pyroptotic macrophages also trap live bacteria inside membrane remnants called pore-induced intracellular traps (PITs), which are then cleared by incoming neutrophils via efferocytosis. In short, the inflammation is the point: it is a loud, deliberate alarm that trades one infected cell for a coordinated immune counterattack.

What is the difference between canonical and non-canonical pyroptosis?

Canonical pyroptosis requires an upstream sensor and the adaptor ASC to activate caspase-1, which then cleaves both gasdermin D and the pro-cytokines pro-IL-1beta and pro-IL-18. The non-canonical pathway skips the sensor entirely: the inflammatory caspases-4 and -5 in humans (caspase-11 in mice) are themselves direct receptors for cytosolic lipopolysaccharide (LPS) from Gram-negative bacteria, binding LPS through their CARD domains. Once oligomerized on LPS, these caspases cleave gasdermin D to drive pore formation and lysis, but they cannot cleave pro-IL-1beta directly. Instead, the resulting potassium efflux through the gasdermin D pore activates the NLRP3 inflammasome secondarily, which recruits caspase-1 to mature the cytokines. So canonical signaling is one integrated step, while non-canonical signaling is caspase-11/4/5 for lysis plus a downstream NLRP3-caspase-1 loop for cytokine release.

How was pyroptosis discovered?

In the 1990s, Arturo Zychlinsky and colleagues noticed that macrophages infected with Shigella died in a caspase-1-dependent, inflammatory way that was clearly not classical apoptosis. In 2001 Brad Cookson and Molly Brennan coined the term 'pyroptosis' — from the Greek pyro (fire) and ptosis (falling) — to name this caspase-1-driven, pro-inflammatory death seen with Salmonella. The molecular executioner stayed hidden until 2015, when two groups, one led by Feng Shao and one by Vishva Dixit with Judy Lieberman, independently used forward-genetic and CRISPR screens to identify gasdermin D as the essential substrate whose cleaved N-terminal fragment forms the lytic pore. The pore-forming mechanism was resolved structurally soon after, and today gasdermins are recognized as an ancient family of pore-forming executioners of inflammatory death.

What diseases involve pyroptosis?

Dysregulated pyroptosis and its inflammasomes drive a spectrum of inflammatory disease. Gain-of-function NLRP3 mutations cause the autoinflammatory cryopyrin-associated periodic syndromes (CAPS), treated with IL-1 blockers such as anakinra, canakinumab, and rilonacept. Familial Mediterranean fever stems from mutations in MEFV, the gene encoding Pyrin. Chronic NLRP3 activation by cholesterol crystals contributes to atherosclerosis, by monosodium urate crystals to gout, and by islet amyloid and metabolic stress to type 2 diabetes; the CANTOS trial showed that the anti-IL-1beta antibody canakinumab reduced recurrent cardiovascular events. Excessive pyroptosis of CD4 T cells driven by caspase-1 is a major cause of the T-cell depletion in HIV infection. Because the gasdermin D pore is the shared bottleneck, its small-molecule inhibitor disulfiram and the NLRP3 inhibitor MCC950 are being pursued as broad anti-inflammatory therapeutics.